Concepedia

W. Iams

WI

Statistics

Publications

1

Citations

10

H-Index

1

Active since

2023

Affiliations

Immutep (Germany)(Current)

W. Iams is an author at Immutep (Germany) specializing in radiation oncology, cancer therapeutics, and pharmacotherapy.

Top concepts

Publications per year

2023–2023

1

Publications

1

11MO Final data from a phase II study (TACTI-002) of eftilagimod alpha (soluble LAG-3) and pembrolizumab in 2nd-line metastatic NSCLC pts resistant to PD-1/PD-L1 inhibitors

M. Majem, M.D. Forster, M.G. Krebs et al. · Journal of Thoracic Oncology · 2023 · 10 citations · Full text

, , +8

1–1 of 1